title: Changes in VEGF expression and in the vasculature during the growth of early-stage ethylnitrosourea-induced malignant astrocytomas in rats.
abstract: Vascular endothelial growth factor (VEGF), a potent angiogenic and vascular permeability factor, may be important as a mediator of brain tumour progression. However, it is still not clear whether VEGF plays a causative role in the early stage of glioma development. We investigated the relationship between VEGF protein expression (as assayed by immunohistochemistry) and different morphological parameters reflecting tumour progression (tumour diameter, vascular density and vascular diameter) in tumours at various stages. As a tumour model, ethylnitrosourea (ENU)-induced rat malignant astrocytoma was used. Tumours were classified by size and level of vascularity estimated by the von Willebrand factor (vWF) staining. Tumours less than 10 mm in diameter were designated early stage neoplastic lesions. All 34 early astroglial tumours were found to be VEGF positive. Increase in the VEGF immunopositive rate of tumour cells correlated significantly with increase in vascular density and vascular diameter. We suggest that VEGF induces angiogenesis and growth of microvessels, promoting growth of the early stage malignant astrocytoma.
authors.affiliation: Department of Neurosurgery, Kurume University School of Medicine, Japan.
authors.forename: F
authors.initials: F
authors.lastname: Yoshimura
authors.forename: T
authors.initials: T
authors.lastname: Kaidoh
authors.forename: T
authors.initials: T
authors.lastname: Inokuchi
authors.forename: M
authors.initials: M
authors.lastname: Shigemori
mesh_terms: D000818:Animals; D001254:Astrocytoma / Q000098:blood supply* / Q000139:chemically induced / Q000473:pathology; D001808:Blood Vessels / Q000378:metabolism / Q000473:pathology; D001932:Brain Neoplasms / Q000098:blood supply* / Q000139:chemically induced / Q000473:pathology; D016228:Endothelial Growth Factors / Q000378:metabolism*; D005038:Ethylnitrosourea; D005260:Female; D007124:Immunoenzyme Techniques; D008222:Lymphokines / Q000378:metabolism*; D009389:Neovascularization, Pathologic / Q000139:chemically induced / Q000378:metabolism* / Q000473:pathology; D011247:Pregnancy; D051381:Rats; D017207:Rats, Sprague-Dawley; D042461:Vascular Endothelial Growth Factor A; D042442:Vascular Endothelial Growth Factors; D014841:von Willebrand Factor / Q000378:metabolism
chemical_list: D016228:Endothelial Growth Factors; D008222:Lymphokines; D042461:Vascular Endothelial Growth Factor A; D042442:Vascular Endothelial Growth Factors; D014841:von Willebrand Factor; D005038:Ethylnitrosourea